Related Experiment Video

Updated: May 19, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Understanding the burden of pneumococcal disease in adults

F Blasi1, M Mantero, PierAchille Santus

  • 1Respiratory Medicine Section, Dipartimento Toraco-Polmonare e Cardiocircolatorio, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico Cà Granda Milan, Milan, Italy. francesco.blasi@unimi.it

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|August 14, 2012
PubMed

Insights

Streptococcus pneumoniae causes pneumonia and invasive infections. Emerging antibiotic resistance and suboptimal vaccine protection highlight the need for new conjugate vaccines for effective adult treatment.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Vaccinology

Background:

  • Streptococcus pneumoniae is a leading cause of community-acquired pneumonia and invasive infections.
  • Pneumococcal pneumonia occurs with bacteremia in 10-30% of cases.
  • Increasing antimicrobial resistance in S. pneumoniae raises concerns about treatment efficacy and mortality.

Purpose of the Study:

  • To review the challenges in managing pneumococcal infections.
  • To evaluate current vaccine efficacy.
  • To explore promising vaccination strategies.

Main Methods:

  • Literature review of S. pneumoniae infections and resistance patterns.
  • Analysis of current vaccine effectiveness data.
  • Assessment of emerging conjugate vaccine research.

Main Results:

  • S. pneumoniae exhibits growing resistance to multiple antimicrobial agents.
  • The 23-valent pneumococcal vaccine provides suboptimal protection, especially in high-risk adults.
  • New conjugate vaccines show promise for improved disease management.

Conclusions:

  • Antibiotic resistance in S. pneumoniae poses a significant clinical challenge.
  • Enhanced vaccination strategies are crucial for controlling pneumococcal disease.
  • Conjugate vaccines represent a promising avenue for improving adult pneumococcal infection management.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: